CN Patent

CN105873935B — 结晶的β-内酰胺酶抑配制品

Assigned to Aoqide Pharmaceutical Co.,Ltd. · Expires 2019-03-19 · 7y expired

What this patent protects

一种式(I)的结晶化合物：式(I)。式(I)化合物是β‑内酰胺酶抑配制品并且可以与抗细菌剂结合给予以用于预防或者治疗细菌感染。

USPTO Abstract

一种式(I)的结晶化合物：式(I)。式(I)化合物是β‑内酰胺酶抑配制品并且可以与抗细菌剂结合给予以用于预防或者治疗细菌感染。

Drugs covered by this patent

chembl-chembl1200962 (CEFEPIME HYDROCHLORIDE)

Patent Metadata

Patent number: CN105873935B
Jurisdiction: CN
Classification: —
Expires: 2019-03-19
Drug substance claim: No
Drug product claim: No
Assignee: Aoqide Pharmaceutical Co.,Ltd.
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.